Cyclin E mRNA: Assessing Cyclin-Dependent Kinase (CDK) Activation State to Elucidate Breast Cancer Resistance to CDK4/6 Inhibitors

Podobne knjige/članki

• Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells
  od: Ogata, Ryohei, et al.
  Izdano: (2020)
• Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
  od: Thill, Marc, et al.
  Izdano: (2018)
• Cyclin‐dependent kinase (CDK) inhibitors for hormone receptor‐positive advanced breast cancer
  od: Syn, Nicholas LX, et al.
  Izdano: (2018)
• Cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6i) versus chemotherapy in luminal B early breast cancer: lessons from the CORALLEEN trial
  od: De Angelis, Claudia, et al.
  Izdano: (2020)
• The awakening of the CDK10/Cyclin M protein kinase
  od: Guen, Vincent J., et al.
  Izdano: (2017)